On Tuesday, Aptose Biosciences Inc (NASDAQ: APTO) opened higher 1.47% from the last session, before settling in for the closing price of $0.18. Price fluctuations for APTO have ranged from $0.13 to $2.91 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 76.39% at the time writing. With a float of $47.46 million, this company’s outstanding shares have now reached $59.52 million.
The extent of productivity of a business whose workforce counts for 35 workers is very important to gauge. In terms of profitability, gross margin is 52.33%, operating margin of -5123.32%, and the pretax margin is -5066.98%.
Aptose Biosciences Inc (APTO) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Aptose Biosciences Inc is 20.27%, while institutional ownership is 5.43%. The most recent insider transaction that took place on Nov 25 ’24, was worth 20,000. In this transaction Chair, President & CEO of this company bought 100,000 shares at a rate of $0.20, taking the stock ownership to the 613,252 shares.
Aptose Biosciences Inc (APTO) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -1.44 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -1.78) by 0.34. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 76.39% per share during the next fiscal year.
Aptose Biosciences Inc (NASDAQ: APTO) Trading Performance Indicators
Check out the current performance indicators for Aptose Biosciences Inc (APTO). In the past quarter, the stock posted a quick ratio of 1.05.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.05, a number that is poised to hit -0.35 in the next quarter
Technical Analysis of Aptose Biosciences Inc (APTO)
The latest stats from [Aptose Biosciences Inc, APTO] show that its last 5-days average volume of 0.92 million was superior to 0.29 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 23.53%. Additionally, its Average True Range was 0.03.
During the past 100 days, Aptose Biosciences Inc’s (APTO) raw stochastic average was set at 9.61%, which indicates a significant decrease from 20.11% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 145.20% in the past 14 days, which was higher than the 89.04% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3493, while its 200-day Moving Average is $0.8292. Now, the first resistance to watch is $0.1971. This is followed by the second major resistance level at $0.2074. The third major resistance level sits at $0.2160. If the price goes on to break the first support level at $0.1782, it is likely to go to the next support level at $0.1696. Assuming the price breaks the second support level, the third support level stands at $0.1593.
Aptose Biosciences Inc (NASDAQ: APTO) Key Stats
There are currently 18,110K shares outstanding in the company with a market cap of 11.11 million. Presently, the company’s annual sales total 0 K according to its annual income of -51,210 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -6,950 K.
